Vendor, San Francisco, CA
Cellsight Technologies, Inc.
UEI E3UQXACGFR43, CAGE 5T0V1
1 award and $0 obligated between September 10, 2024 and September 15, 2025, 100% under full and open competition, against 2.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $0 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition After Exclusion of Sources | 1 |
| Small Business Set Aside - Total | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N91022C00015Definitive Contract, September 10, 2024, Full and Open Competition After Exclusion of Sources, 2 offers | NIH NCINational Institutes of Health | SBIR Phase II - Topic 396 - Imaging for Cancer ImmunotherapiesNAICS 541715, PSC AN12 | $0 |
- Places of performance
- California
- Product and service codes
- AN12 Health R&D Services; Health Care Services; Applied Research
- Transactions
- 2 across 1 awards